Has Ajay Ponugoti, MD received payments from drug or device companies?

Yes. Drug and device makers reported $812 in general payments to Ajay Ponugoti, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ajay Ponugoti, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ajay Ponugoti, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ajay Ponugoti, MD

Hospitalist · Greenwood, INNPI 1801876396

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Radius Health, Inc. at 29.9% of the total. Reporting peaked in 2019 at $610 and has fallen 96.3% since, to $22 in 2023.

$812in general payments, 2019–2025

Across 24 payments — averaging $33.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Radius Health, Inc.$243
GSK$163
Harmony Biosciences LLC$120
The Cameron-ehlen Group, Inc.$111
Novartis$100
AbbVie$37
plus $39 from 2 others

What the payments were for

Food & beverage$79898%
Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Radius Health, Inc.	2	$243
GSK	15	$163
Harmony Biosciences LLC	1	$120
The Cameron-ehlen Group, Inc.	1	$111
Novartis	1	$100
AbbVie(2 entities)	2	$37
Johnson & Johnson	1	$22
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tymlos$243
Wakix$120
Cyclosporine/Chondroitin PF$111
Dex-Moxi$111
MKO Melt$111
Phenyl-Lido$111
Triamcinolone-Moxifloxacin PF$111
ENTRESTO$100

How this compares

$812 in reported general payments places this provider in the 85th percentile of 423 hospitalist providers in Indiana.

See all hospitalist providers in Indiana →

Medicare billing

Part B allowed, 2024

$136,220

Medicare patients

594

Services billed

1,331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Breo ElliptaFluticasone/Vilanterol	11	$4,835
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	31	$184
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$160
Pantoprazole Sodium	19	$149
Doxycycline Monohydrate	16	$121
Cephalexin	15	$86
Prednisone	17	$75
Amlodipine Besylate	21	$17

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
GSKBreo Ellipta	$163	$4,83511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 423 hospitalist providers in Indiana.

Other hospitalist in Greenwood

Ashraf AbdelhafezGreenwood$1K
Bisher ZuhdiGreenwood$915
Brendan SweenyGreenwood$730
Joseph AbdayemTerre Haute$13K
James KruegerEvansville$11K
Yu LiuDecatur$6K
Laarni MorenoElkhart$5K
Harold RahmingDyer$5K
Jai Kumar KhatriIndianapolis$4K
Sanjay RaikarMichigan City$3K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →